Puder
Arno Puder, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20140316826 | WIRELESS CARRIER PLATFORM FOR SERVICE APPLICATIONS - A method for providing customized service applications relating to specific transactions with merchants to users of mobile devices includes: receiving and storing a service application template corresponding to a merchant; receiving a manifest including information relating to a specific transaction between the merchant and a user of a mobile device; extracting the information relating to the specific transaction from the manifest; generating a customized service application for the user based on the service application template and the extracted information; and transmitting the customized service application to the mobile device corresponding to the user. | 10-23-2014 |
Carsten Puder, Ingelheim Am Rhein DE
Patent application number | Description | Published |
---|---|---|
20130225804 | NOVEL METHOD FOR MANUFACTURING OF CICLESONIDE - The invention relates to a process for preparing the corticosteroid ciclesonide, used for the treatment of respiratory complaints, in epimerically pure form of formula 1: | 08-29-2013 |
Carsten H. Puder, Ingelheim Am Rhein DE
Patent application number | Description | Published |
---|---|---|
20100331544 | METHOD FOR PRODUCING (1R,5S) ANHYDROECGONINE ESTER SALTS - The invention relates to a large-scale method for producing salts of (IR,5S) anhydroecgonine esters. The salt formation and selective crystallization of (IR,5S) anhydroecgonine esters with chiral acids is highly efficient in producing an enantiomer form, any undesired enantiomers and other impurities being removed. The ester and its salts are used as the starting material for producing active agents. | 12-30-2010 |
George Puder, Honolulu, HI US
Patent application number | Description | Published |
---|---|---|
20120023593 | SYSTEM AND METHOD FOR FILTERING INTERNET CONTENT & BLOCKING UNDESIRED WEBSITES BY SECURE NETWORK APPLIANCE - A secure network appliance for filtering Internet websites checks each request from a user's browser against a whitelist of pre-approved websites and passes it only if it is on the whitelist. Otherwise, the request is replaced with pre-arranged content and returned as a response to the user's web browser. It can also check the port the user's request came through against an approved ports whitelist, and responses sent from the Internet against an approved websites whitelist. The network appliance is encapsulated within a secure container so that only an authorized administrator having a unique key can unlock it and access its control functions. The secure container may be formed as a separate hardware component that is physically interposed between a router and a user's computer, or as secure software that run on or operates with a network server. | 01-26-2012 |
Hanning Puder, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20090290734 | HEARING APPARATUS WITH AN EQUALIZATION FILTER IN THE FILTER BANK SYSTEM - Multi-stage filter bank systems with filter banks of different bandwidth frequently cause interference in hearing apparatuses and in particular in hearing devices. Therefore a hearing apparatus is proposed with a filter bank system having a multi-stage analysis filter bank and/or a multi-stage synthesis filter bank, to break down an input signal of the hearing apparatus into a number of partial band signals by way of a number of filter bank channels and/or to recombine partial band signals of a number of filter bank channels. The filter bank system is equipped with at least one equalization filter, to equalize differences in the complex frequency responses between filter bank channels. It is thus possible in particular to equalize group delay time differences as well as attenuation and/or amplification | 11-26-2009 |
Henning Puder, Erlangen, DE US
Patent application number | Description | Published |
---|---|---|
20090129608 | Method for reducing interference powers and corresponding acoustic system - The object is to improve the action of a directional microphone in real acoustic environments. To do this, it is envisaged that the interference powers in a directional microphone with three microphones are reduced in that a first and a second microphone signal are adaptively filtered with respect to a first direction, with a direction-determining first parameter being adapted in such a way that the summation of interference powers is reduced. The second and a third microphone signal is adaptively filtered with respect to the first direction, with a direction-determining second parameter being adapted in such a way that the summation of interference powers is reduced. The two parameters are different from each other. This makes it possible, even in real environments, to suppress two interference sources from different directions with one second-order directional microphone. | 05-21-2009 |
Katja Puder, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20160037807 | Method for Reducing the Level of Asparagine in a Food Material - The present invention relates to a method for reducing the level of asparagine in a food material to be heat-treated comprising soaking the food material in water and contacting at least part of the soaking water with an immobilized asparaginase. | 02-11-2016 |
Katja Puder, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20160128366 | Method for Producing a Food Product - The present invention relates to a method for producing a heat-treated food product from a food material which has been contacted with an asparaginase. | 05-12-2016 |
20160135486 | Method for Producing a Food Product - The present invention relates to a method for producing a heat-treated food product from a food material which has been contacted with an asparaginase. | 05-19-2016 |
20160138003 | Method for Producing a Food Product - The present invention relates to a method for producing a heat-treated food product from a food material which has been contacted with an asparaginase. | 05-19-2016 |
Mark Puder, Medfield, MA US
Patent application number | Description | Published |
---|---|---|
20080275119 | Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN) - The present invention is based on the discovery that parenteral nutrition (PN) induced liver disease, e.g. fatty liver disease, can be prevented and even reversed by administration of primarily omega-3-fatty acid with PN rather than the administration of the standard intravenous lipid emulsions that contain primarily plant derived omega-6 fatty acid. Thus, the present invention provides a method for treating or preventing liver disease in a human patient obtaining nutritional support through PN. The method comprises intravenous administration of an effective amount of an omega-3-fatty acid emulsion to the patient, wherein the patient is not administered phytosterols or plant derived fatty acids, e.g. omega-6 fatty acids derived from a plant source, and wherein the administration of the omega-3-fatty acid emulsion to the patient is for a period greater than three weeks. Preferably, the administration is for a period of greater than six weeks. More preferably, the administration is for a period greater than three months. | 11-06-2008 |
20090221533 | METHOD OF TREATING FATTY LIVER DISEASE - The present invention relates to a method for treating a fatty liver disease or disorder in a patient in need thereof. The method comprises administering at least one matrix metalloproteinase (“MMP”) inhibitor to the patient. Fatty liver disease or disorders include, for example, NAFLD, NASH, ALD, fatty liver associated with chronic hepatitis infection, TPN, steroid treatment, tamoxifen treatment, gastrointestional operations, diabetes and Reye's Syndrome. The method is particularly useful when the fatty liver disease is associated with TPN and the patient is an infant or when the patient is obese. MMP inhibitors useful in the present invention include, for example, Marimastat, tetracyclines, Prinomastat, Batimastat, BAY 12-9566, AG3340, BMS-275291, Neovastat, BB-3644, KB-R7785, TIMP1, TIMP2, doxycycline, minocycline, RS-130,830; CGS 27023A, Solimastat, Ro 32-3555, BMS-272591, and D2163. Marimastat is a preferred MMP inhibitor. | 09-03-2009 |
20100222371 | PREVENTION OF SURGICAL ADHESIONS - The present invention relates to methods for treatment (particularly the prevention or suppression) of formation or reformation of adhesions, particularly in the peritoneal or pelvic cavities resulting from wound, surgery, infection, inflammation or trauma. The invention provides methods useful for inhibiting, suppressing or ameliorating adhesion formation in mammals, including humans wherein an individual is administered a compound selected from the group consisting of sunitinib malate, axitinib, semaxanib, sorafenib, ZD1839, and erlotinib. The invention applies to human and veterinary applications. The inventive method has been shown to be especially effective in preventing adhesion formation in the peritoneum following surgery. | 09-02-2010 |
20140194511 | DIETARY FORMULATIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND OTHER DISORDERS - Dietary formulations in the form of an oil emulsion providing total enteral or parenteral nutrition, or in the form of food oil suitable for oral administration is provided. The formulations include about 2-60% by calories of a C | 07-10-2014 |
20150025048 | METHODS FOR ENHANCING, IMPROVING, OR INCREASING FERTILITY OR REPRODUCTIVE FUNCTION - The present disclosure is directed to methods for enhancing, improving or increasing fertility or reproductive function. For example, the present disclosure is directed to a method for enhancing, improving, or increasing a female human's likelihood of becoming pregnant comprising: administering to the human a nutritional, dietary, or food fatty acid supplement comprising: at least 30% docosahexaenoic acid (DHA), by weight of the total fatty acids in the supplement in a form chosen from ethyl ester, free fatty acid, and triglyceride. | 01-22-2015 |
20160045468 | NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF CANCERS AND RELATED THERAPIES AND METHODS - Disclosed herein are compositions and methods for treating or preventing certain cancers in a subject. In certain embodiments such compositions and methods generally relate to the use of G-coupled protein receptor 40 (GPR40) agonists to inhibit the growth or induce apoptosis of certain cancer cells. The compositions and related methods disclosed herein may be used to treat subjects affected by cancers, such as melanoma, medullary thyroid carcinoma, malignant peripheral nerve sheath tumors and neuroblastoma, and to reduce the incidence of metastases in such affected subjects. | 02-18-2016 |